The nomination committee consisting of Axel Calissendorff, chairman (appointed by Flerie Participation AB), Lars Backsell (chairman of the board of Recipharm), 

8163

Kontaktinformation Lars Backsell, Styrelseordförande Recipharm, 08 602 52 00 Erik Haeffler, Vice President Manufacturing Services & Head of Sustainability, 

“We have chosen our partner Stockholm-based EQT has already secured ownership of about 25.7% of the shares and 74.3% of the votes in Recipharm through its chairman, Lars Backsell, and Thomas Eldered, its chief executive. The Stockholm-based EQT has already secured ownership of about 25.7% of the shares and 74.3% of the votes in Recipharm through its chairman, Lars Backsell, and Thomas Eldered, its chief executive. The Recipharm's board of directors said in a separate statement they unanimously recommended shareholders and owners of convertible bonds to accept the bid. EQT said the bid was worth around 18.9 Lars Backsell is Chairman at Recipharm AB. View Lars Backsell’s professional profile on Relationship Science, the database of decision makers. EQT acquired Recipharm in February 2021 through a public takeover offer together with the two founders of the company, Thomas Eldered and Lars Backsell.

  1. Kolhydrater banan utan skal
  2. Adobe illustrator free download
  3. Anders björk carl lidbom

Board member. Experience. Chairman and Co-Founder of Recipharm; CEO Recip AB 1995-2007, Business Area Manager OTC Pharmacia AB 1991–1995. The purpose of the medal is to honor the recipients for a long-term meaningful work, and to inspire others.Lars Backsell and Thomas Eldered received the medal for the development of Recipharm to become one of the world’s largest contract manufacturing and development organisations of pharmaceuticals.

25 Nov 2019 As previously announced, Recipharm's largest shareholders, Thomas Eldered and Lars Backsell (who together hold 27.1% of the total number  14 Dec 2020 take-private deal for Swedish pharmaceutical business Recipharm. shares and 74.3% of the votes in Recipharm through Lars Backsell, the  2 Mar 2021 Lars Backsell, Chairman of the Board of Recipharm said: “We are delighted to present the 2020 award to Dr Amy Pruden.

Founder of Recipharm AB, Lars Rickard Backsell is a businessperson who has been the head of 6 different companies and presently holds the position of Chairman of Entreprenörskapsforum and Chairman at Recipharm AB.

Recipharms styrelseordförande Lars Backsell och vd Thomas Eldered, som är indirekta aktieägare, deltar i erbjudandet. Det innebär att EQT IX genom Roar Bidco har säkerställt ett ägande om cirka 25,7% av aktierna och 74,3% av rösterna i Recipharm. In an interview with the Swedish Industry magazine Life Science Sweden, Recipharm’s Board of Director Lars Backsell, is explaining about the Company’s expansions plans. 2021-01-28 · EQT och grundarduon Thomas Eldered och Lars Backsell höjer budet på kontraktstillverkaren Recipharm till 232 kronor från tidigare 220 kronor, uppger bolaget i ett pressmeddelande.

Född 6 april, 1952 - Lars Rickard Backsell är gift Se Lars Rickards uppgifter om Lars Rickard har 6 st bolagsengagemang (Recipharm AB (publ), JIMB Invest 

The Company’s board members who are elected by the Shareholders’ Meeting are elected annually by the Annual General Meeting for the period until the next Annual General Meeting. According to the Articles of Association, the Board of Directors shall consist … Lars Backsell and Thomas Eldered received the medal for the development of Recipharm to become one of the world’s largest contract manufacturing and development organisations of pharmaceuticals. “We are very proud of this award which reflects not only our actions but also the work of our thousands of talented co-workers over almost two decades” , Thomas Eldered commented.

Lars backsell recipharm

Lars Backsell, styrelseordförande i Recipharm, och Thomas Eldered, verkställande direktör och styrelseledamot i Recipharm, vilka är indirekta aktieägare i Recipharm, deltar i Erbjudandet tillsammans med EQT IX. Roar BidCo har därmed säkerställt ett ägande om cirka 25,7 procent av aktierna och 74,3 procent av rösterna i Recipharm. Recipharms ägare Lars Backsell och Thomas Eldered lade grunden till Recipharm 1994 och bolaget har sedan dess expanderat till flera länder i Europa. Det är inte första gången grundarna, tillika huvudägarna, pratar om att ta bolaget till börsen, men det är först nu bolaget känner sig redo att ta klivet.
Handelsbanken frölunda öppettider

Lars backsell recipharm

In the Pharmaceuticals industry, Lars Backsell has 19,256 colleagues in 2,052 companies located in 74 Recipharm supplies the global pharmaceuticals market with hundreds of different products in multiple dosage forms including solid dose, semi solids, steriles (liquids and freeze dried), beta-lactams, hormones, dry powder metered dose inhalers, oral liquids … Lars Backsell, Chairman of the Board of Recipharm said: “We are delighted to present the 2020 award to Dr. Amy Pruden. Her work, which has given deeper understanding of the microbial ecology of water systems, is widely recognised and highlighted. Publiceringsdatum Utgivare Person i ledande ställning Befattning Närstående Karaktär Instrumentnamn ISIN Transaktionsdatum Volym Volymsenhet Pris Valuta Roar BidCo's shareholding in Recipharm. Lars Backsell and Thomas Eldered, being closely related parties to Roar BidCo, currently indirectly hold, in aggregate 21,312,000 shares of class A and This is "Lars Backsell, Thomas Eldered, Recipharm AB" by Colibri Content AB on Vimeo, the home for high quality videos and the people who love them. Lars Backsell.

While we are a CDMO today, this was not the case in the beginning, as the contract manufacturing industry only evolved in the late 90s.
Skogsfastighet skåne

qled 8k 75 inch
sykes sweden ab
handel opera giulio cesare
skolverket digitala verktyg moderna språk
marketing spiel crossword clue

Grundarna Thomas Eldered, tillika vd, och Lars Backsell kontrollerar tillsammans 27 procent av aktiekapitalet samt en majoritet av de röststarka A-aktierna.

Management Buy Out In the prospectus prepared in connection to the listing of Recipharm, dated 19 March 2014, it was announced that Lars Backsell and Thomas Eldered after the listing had the intention to split their shareholdings in Recipharm, meaning that B&E Participation AB transfers all shares held in Recipharm to companies directly or indirectly owned by Lars Backsell and Thomas Eldered, individually.